Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-Oesophageal Junction Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01246960
What this trial is testing

Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer

Who this might be right for
Stomach CancerEsophageal Cancer
Eli Lilly and Company 168
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Testing effectiveness (Phase 2)UnknownNCT01095120
What this trial is testing

Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer

Who this might be right for
Adenocarcinoma of the StomachAdenocarcinoma of Esophagogastric Junction
Genta Incorporated 27
Testing effectiveness (Phase 2)Looking for participantsNCT07262619
What this trial is testing

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Who this might be right for
Advanced Solid TumorsMSI-H or dMMR Advanced Solid TumorsMSI-H/dMMR Gastric Cancer+4 more
Eikon Therapeutics 160
Not applicableNot Yet RecruitingNCT07408999
What this trial is testing

Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer

Who this might be right for
Resecable Esophageal or Gastroesophageal Junction Cancer
University Hospital, Lille 327
Testing effectiveness (Phase 2)Ended earlyNCT00442507
What this trial is testing

Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Esophageal NeoplasmsEsophageal Diseases
Washington University School of Medicine 6
Testing effectiveness (Phase 2)Study completedNCT00517829
What this trial is testing

Docetaxel+Oxali+/-Cetux Met Gastric/GEJ

Who this might be right for
Gastric Cancer Adenocarcinoma Metastatic
US Oncology Research 150
Not applicableStudy completedNCT06412575
What this trial is testing

JNT Versus TNT to Guided OGT-overlap Oesophagojejunostomy

Who this might be right for
Gastric/Gastroesophageal Junction (g/Gej) Cancer
Nanfang Hospital, Southern Medical University 108
Not applicableLooking for participantsNCT06558786
What this trial is testing

Registry for Esophageal and Gastroesophageal Junction Cancer

Who this might be right for
Gastroesophageal-junction CancerEsophageal Cancer
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT01774851
What this trial is testing

MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach

Who this might be right for
HER-2 Gene AmplificationEsophagus CancerGastroesophageal Junction Cancer+1 more
Merrimack Pharmaceuticals 84
Testing effectiveness (Phase 2)UnknownNCT03030937
What this trial is testing

Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA

Who this might be right for
Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
Fujian Cancer Hospital 74
Large-scale testing (Phase 3)Ended earlyNCT01697072
What this trial is testing

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric Cancer
Amgen 609
Testing effectiveness (Phase 2)Looking for participantsNCT05687357
What this trial is testing

Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal-junction Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 140
Not applicableActive Not RecruitingNCT04878783
What this trial is testing

Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG

Who this might be right for
Gastric CancerAdenocarcinoma of the Stomach
University of Roma La Sapienza 138
Large-scale testing (Phase 3)UnknownNCT02512380
What this trial is testing

Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer

Who this might be right for
Gastric Adenocarcinoma
Chinese Academy of Medical Sciences 380
Testing effectiveness (Phase 2)Looking for participantsNCT06329973
What this trial is testing

Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer

Who this might be right for
Metastatic Gastroesophageal Junction Adenocarcinoma
Henan Cancer Hospital 70
Not applicableLooking for participantsNCT05450835
What this trial is testing

OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method

Who this might be right for
Gastric Cancer
Nanfang Hospital, Southern Medical University 344
Early research (Phase 1)Looking for participantsNCT06657144
What this trial is testing

CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Coherus Oncology, Inc. 154
Large-scale testing (Phase 3)Not Yet RecruitingNCT06411171
What this trial is testing

Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer:

Who this might be right for
Gastroesophageal Junction Cancer
xiaohua li 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06238167
What this trial is testing

Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC

Who this might be right for
Gastric Cancer
First Affiliated Hospital of Wenzhou Medical University 40
Next Page